These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 21803099)
21. The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria. Karch CP; Doll TAPF; Paulillo SM; Nebie I; Lanar DE; Corradin G; Burkhard P J Nanobiotechnology; 2017 Sep; 15(1):62. PubMed ID: 28877692 [TBL] [Abstract][Full Text] [Related]
22. Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds. Lozano JM; Guerrero YA; Alba MP; Lesmes LP; Escobar JO; Patarroyo ME Amino Acids; 2013 Oct; 45(4):913-35. PubMed ID: 23836419 [TBL] [Abstract][Full Text] [Related]
23. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies. Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663 [TBL] [Abstract][Full Text] [Related]
24. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA. Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946 [TBL] [Abstract][Full Text] [Related]
26. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display. Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824 [TBL] [Abstract][Full Text] [Related]
27. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum. Pawan K; Ivanov BB; Kabilan L; Rao DN Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572 [TBL] [Abstract][Full Text] [Related]
28. Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332. Ahlborg N; Andersson R; Perlmann P; Berzins K Immunology; 1996 Aug; 88(4):630-5. PubMed ID: 8881768 [TBL] [Abstract][Full Text] [Related]
29. Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen. Ramasamy R; Jones G; Lord R Immunol Lett; 1990 Feb; 23(4):305-9. PubMed ID: 1693361 [TBL] [Abstract][Full Text] [Related]
30. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309 [TBL] [Abstract][Full Text] [Related]
31. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display. Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]
33. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine. Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750 [TBL] [Abstract][Full Text] [Related]